Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles.
Parkinson s drug shows promise in delaying symptoms of ALS | Health kulr8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kulr8.com Daily Mail and Mail on Sunday newspapers.